MKI67 and cancer: The results revealed that the ratio of Ki67+ cells to CD20+ cells was not significantly different among RLN, DLBCL, and AITL tissues, while the ratio of Ki67+ cells to CD8+ cells was significantly different among the cancer tissues (p = 0.0001).